| scholarly article | Q13442814 |
| P2093 | author name string | Au JL | |
| Wientjes MG | |||
| Jang SH | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| paclitaxel | Q423762 | ||
| P304 | page(s) | 1035-1042 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule | |
| P478 | volume | 296 |
| Q37689857 | Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology |
| Q35756974 | Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin |
| Q36791673 | Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities |
| Q36043818 | Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor |
| Q33613579 | Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model |
| Q36920351 | Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. |
| Q35563687 | Drug delivery and transport to solid tumors |
| Q36731526 | Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification |
| Q33698791 | Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids |
| Q30401826 | Extracellularly activatable nanocarriers for drug delivery to tumors. |
| Q26999332 | Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? |
| Q36848111 | Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming |
| Q34789701 | Intraperitoneal therapy for peritoneal cancer |
| Q49118164 | Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence |
| Q35091415 | Intratumoral drug delivery with nanoparticulate carriers |
| Q27300805 | Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia |
| Q64991479 | Magnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer. |
| Q47607986 | Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine |
| Q92617950 | Modelling drug transport during intraperitoneal chemotherapy |
| Q38933699 | Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? |
| Q36092777 | Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors |
| Q35028196 | Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures |
| Q34294361 | Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib |
| Q92617881 | Pharmacokinetic problems in peritoneal drug administration: an update after 20 years |
| Q90655316 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer |
| Q30426788 | Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors |
| Q38567353 | Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors |
| Q33564844 | Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model |
| Q36497582 | Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacy |
| Q36339786 | TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma. |
| Q39408049 | The distribution and retention of paclitaxel and doxorubicin in multicellular layer cultures |
| Q39557339 | Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies |
| Q41997550 | Time- and concentration-dependent penetration of doxorubicin in prostate tumors |
| Q41814813 | Towards an integrated systems-based modelling framework for drug transport and its effect on tumour cells |
| Q50082408 | Transport of drugs from blood vessels to tumour tissue. |
| Q36218165 | Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model |
| Q37415227 | Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer |
| Q27687617 | Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer |
Search more.